Guminski, Alexander, Nicholas Squittieri, and John T Lear. “Adverse Events of Special Interest in Patients With Advanced Basal Cell Carcinoma Receiving Sonidegib: Long-Term 42-Month Results from the BOLT Study”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s67. Accessed July 3, 2024. https://jofskin.org/index.php/skin/article/view/1016.